Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.320.350.360.360.34

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.32 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.32
Mar20250.35
Mar20240.36
Mar20230.36
Mar20220.34

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.32
-8.57
Mar2025 0.35
-2.78
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹69,477.6 Cr -0.1% 7.7% 26.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.1%

7.7%

26.5%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses